These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35916826)

  • 1. Eyelid edema following the first Pfizer-BioNTech COVID-19 vaccination: is it a coincidence?
    Baysal Z; Gobeka HH
    Eur Rev Med Pharmacol Sci; 2022 Jul; 26(14):5264-5267. PubMed ID: 35916826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community.
    Abukhalil AD; Shatat SS; Abushehadeh RR; Al-Shami N; Naseef HA; Rabba A
    BMC Infect Dis; 2023 Jan; 23(1):5. PubMed ID: 36604613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged angioedema after Pfizer-BioNTech COVID-19 vaccine.
    Muhamad Fauzi SM
    BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36882264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Allergy to Pfizer-BioNTech® vaccine demonstrated by skin testing].
    Estrada-García CD; Macías-Robles AP; Cortés-Grimaldo RM; Carvajal-Alonso HL; Barreto-Alcalá M; Ramírez-Nepomuceno A; Esparza-Amaya D; Coronado-Hernández KG; Barrios-Díaz B; Campos-Téllez HH
    Rev Alerg Mex; 2023 Jan; 69(2):89-92. PubMed ID: 36928249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.
    ;
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(2):46-51. PubMed ID: 33444297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Skin reactions to the Pfizer-BioNTech vaccine for COVID-19. An Ecuadorian experience].
    Chérrez-Ojeda I; Robles-Velasco K; Osorio MF; Mejía-Leiva D; Chérrez A; Chérrez S; Bernstein JA; Sarfraz Z; Félix M
    Rev Alerg Mex; 2022 Jun; 69(1):61-64. PubMed ID: 36927752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral Relentless Placoid Chorioretinitis Following Pfizer-BioNTech COVID-19 Vaccination: Specific Antigenic Trigger or Nonspecific Immune Activation?
    Dutt DDCS; Lam J; Richards J
    Ocul Immunol Inflamm; 2024 Sep; 32(7):1498-1503. PubMed ID: 37552853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5-11 Years - United States, May 17-July 31, 2022.
    Hause AM; Baggs J; Marquez P; Myers TR; Su JR; Hugueley B; Thompson D; Gee J; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2022 Aug; 71(33):1047-1051. PubMed ID: 35980875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vulvar Aphthous Ulcer Following Pfizer-BioNTech COVID-19 Vaccine - A Case Report.
    Drucker A; Corrao K; Gandy M
    J Pediatr Adolesc Gynecol; 2022 Apr; 35(2):165-166. PubMed ID: 34718079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Panuveitis following Vaccination for COVID-19.
    Mudie LI; Zick JD; Dacey MS; Palestine AG
    Ocul Immunol Inflamm; 2021 May; 29(4):741-742. PubMed ID: 34213988
    [No Abstract]   [Full Text] [Related]  

  • 12. Reporting of Allergic Reactions During Pfizer-BioNTech BNTT162B2 Vaccination in Israel.
    Anis E; Preis SA; Cedar N; Tal Y; Hershkowitz I; Hershko AY
    J Allergy Clin Immunol Pract; 2022 Nov; 10(11):2969-2976. PubMed ID: 35872216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022.
    Hause AM; Baggs J; Marquez P; Abara WE; Olubajo B; Myers TR; Su JR; Thompson D; Gee J; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(9):347-351. PubMed ID: 35239637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.
    Shavit R; Maoz-Segal R; Iancovici-Kidon M; Offengenden I; Haj Yahia S; Machnes Maayan D; Lifshitz-Tunitsky Y; Niznik S; Frizinsky S; Deutch M; Elbaz E; Genaim H; Rahav G; Levy I; Belkin A; Regev-Yochay G; Afek A; Agmon-Levin N
    JAMA Netw Open; 2021 Aug; 4(8):e2122255. PubMed ID: 34463744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases.
    Petruzzi M; Galleggiante S; Messina S; Della Vella F
    BMC Oral Health; 2022 Mar; 22(1):90. PubMed ID: 35331228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical Presentation of Erythema Nodosum Following Pfizer-BioNTech COVID-19 Vaccine.
    Alzoabi N; Alqahtani J; Algamdi B; Almutairi M; Alratroot J; Alkhaldi S; Alqahtani S; Alakloby O
    Med Arch; 2022 Feb; 76(1):72-74. PubMed ID: 35422564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine.
    Abi Zeid Daou C; Natout MA; El Hadi N
    J Med Virol; 2021 Oct; 93(10):6027-6029. PubMed ID: 34050949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythema Multiforme Reactions Following Pfizer/BioNTech (Tozinameran) Vaccination: Two Case-Reports with Positive Rechallenge and Review of the Literature.
    Charfi O; Lakhoua G; Berrim K; Kastalli S; Badri T; Aouinti I; Daghfous R; Zaiem A; Aidli SE
    Curr Drug Saf; 2024; 19(4):465-468. PubMed ID: 37489779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Course of New-Onset Ocular Myasthenia Gravis Caused by Pfizer-BioNTech COVID-19 Vaccine.
    Su WY; Lu CJ
    Acta Neurol Taiwan; 2023 Dec; 32(4)():218-222. PubMed ID: 37723915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.